SCA
LLY icon

Sensenig Capital Advisors’s Eli Lilly LLY Stock Holding History

Sensenig Capital Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$212K Buy
+177
New +$181K 0.19% 33
2026
Q1 		– Sell
-238
Closed -$256K – 36
2025
Q4 		$256K Buy
+238
New +$228K 0.26% 29

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sensenig Capital Advisors's LLY Position: Q2 2026 in Review

Sensenig Capital Advisors opened a new position in Eli Lilly (LLY) in Q2 2026: 177 shares worth $212K. The stake represents 0.19% of the portfolio and ranks #33 among its holdings. This is a return to the name: Sensenig Capital Advisors previously reported a position in LLY as recently as Q4 2025.

Sensenig Capital Advisors first reported a position in LLY in Q4 2025 and has held it in 2 quarters since. The position peaked at $256K in Q4 2025. 4,593 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Sensenig Capital Advisors held 177 shares of Eli Lilly worth $212K as of Q2 2026.
  • Eli Lilly was a new Sensenig Capital Advisors position in Q2 2026.
  • Eli Lilly made up 0.19% of Sensenig Capital Advisors's portfolio in Q2 2026, its #33 holding.
  • Sensenig Capital Advisors first reported a position in Eli Lilly in Q4 2025 and has held it in 2 quarters since.
  • Sensenig Capital Advisors's Eli Lilly position peaked at $256K in Q4 2025.
  • 4,593 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Sensenig Capital Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.